Call for Abstract

4th World Congress on Cancer Science & Therapy, will be organized around the theme “Enhanced diagnosis, treatment and management of different cancers”

Cancer Science-2014 is comprised of 10 tracks and 60 sessions designed to offer comprehensive sessions that address current issues in Cancer Science-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Cancer stem cells and metastatic growth
  • Track 1-2Cell signaling and membrane proteins: Inflammation and inflammatory factors in cancer development
  • Track 1-3Metastatic cell growth and adhesion: Apoptosis and cell division
  • Track 1-4Biomarkers in cancer therapy and molecular diagnostics
  • Track 1-5DNA methylation and mutation based biomarkers, prognostic biomarkers
  • Track 1-6Biomarkers based on cancer types
  • Track 2-1Organ cancers: Breast, lung, brain, skin, and sarcomas
  • Track 2-2Liver, prostate, kidney, ovarian and cervical cancer
  • Track 2-3Blood, lung and leukemia cancer
  • Track 2-4Bone and thyroid cancer
  • Track 2-5Gastrointestinal and colorectal cancer
  • Track 3-1Biomarkers in cancer detection
  • Track 3-2Chemoprevention
  • Track 3-3Environmental factors
  • Track 3-4Chemotherapy of cancers
  • Track 3-5Cancer Epidemiology
  • Track 4-1Tumor virology
  • Track 4-2Tumor immunology and immunotherapy
  • Track 4-3Tumor microenvironment and research
  • Track 4-4Tumor varieties: Benign, pre-malignant, and malignant
  • Track 4-5Tumor progression, invasion and metastasis
  • Track 5-1Molecular cancer therapeutics
  • Track 5-2Clinical and potential applications of metabolomics in oncology
  • Track 5-3Metabolomics in novel biomarker discovery
  • Track 5-4Revisiting tumor metabolism
  • Track 5-5Telomerase: A target for cancer therapeutics
  • Track 5-6Analytical and bio-analytical techniques in metabolomics
  • Track 5-7Transcriptomics
  • Track 5-8Toxicology and drug metabolism
  • Track 6-1Cancer: Gene expression and protein profiling; Surgery and laparoscopy
  • Track 6-2Radiotherapy and chemotherapy
  • Track 6-3Hormone replacement therapy
  • Track 6-4Molecular-targeted therapies
  • Track 6-5Clinical medicine and targeting anti cancer drugs
  • Track 6-6Therapeutic targets in cancer
  • Track 6-7Clinical research in cancer immunology
  • Track 6-8Anticancer gene therapy and stem cells therapy
  • Track 6-9Cancer metabolism
  • Track 6-10Molecular cancer biology
  • Track 7-1Metabolism of carcinogens
  • Track 7-2Biological and external factors for carcinogenesis
  • Track 7-3Cancer Research: Clinical and experimental oncology
  • Track 7-4Cancer cell lines: Genomics and proteomics
  • Track 8-1New cancer biomarkers as drug targets
  • Track 8-2Anticancer drugs targeting protein kinase inhibitors
  • Track 8-3Anticancer drugs targeting Tumor Necrosis Factor (TNF) and chemokine receptors
  • Track 8-4Antibodies for cancer therapy
  • Track 8-5Anticancer drugs targeting signalling pathways and regulators
  • Track 8-6Anticancer drugs targeting GPCR, nuclear receptor inhibitors and hormonal therapies
  • Track 8-7Apoptotic inducers, targeting apoptosis signaling pathways and their mediators
  • Track 9-1Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers
  • Track 9-2Metabolomics in novel biomarker discovery
  • Track 9-3Clinical and prospective applications of metabolomics in oncology
  • Track 9-4Analytical and Bio-Analytical Techniques in Metabolomics
  • Track 9-5Current Trends and Innovations in Metabolomics
  • Track 9-6Metabolomics Syndrome
  • Track 9-7Toxicology and Drug Metabolism
  • Track 9-8Stem cell therapy in cancer
  • Track 9-9Neuro-Oncology
  • Track 9-10Cancer Ethics